NCT02598479

Brief Summary

The IPTLD QoL Broad Study.

Trial Health

30
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Timeline
Completed

Started Nov 2015

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 1, 2015

Completed
3 days until next milestone

First Submitted

Initial submission to the registry

November 4, 2015

Completed
2 days until next milestone

First Posted

Study publicly available on registry

November 6, 2015

Completed
2.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2018

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2018

Completed
Last Updated

August 28, 2018

Status Verified

August 1, 2018

Enrollment Period

2.8 years

First QC Date

November 4, 2015

Last Update Submit

August 27, 2018

Conditions

Cancer

Keywords

CancerInsulin Potentiation Low Dose ChemotherapyIPTIPTLDNutrition therapy

Outcome Measures

Primary Outcomes (1)

  • Improvement in Quality of Life measured by questionnaires

    Improvement in Quality of Life using Insulin Potentiation Low Dose Chemotherapy and Nutrition Therapy for the Treatment of Cancer, as measured by MD Anderson's MDASI questionnaires

    5 years

Study Arms (1)

IPTLD and nutrition therapy

Patients presenting to the Arizona Center for Advanced Medicine for the treatment of cancer using Insulin Potentiation Low Dose Chemotherapy and Nutrition Therapy

Other: IPTLD and nutrition therapy

Interventions

IPTLD and nutrition therapyOTHER

The measurement of Quality of Life in patients who choose to use Insulin Potentiation Low Dose Therapy and Nutritional Therapy in the treatment of cancer

IPTLD and nutrition therapy

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients over the age of 18 who have chosen to receive IPTLD with nutrition therapy

You may qualify if:

  • diagnosis of cancer,
  • age older than 18 years,
  • requesting IPTLD and nutrition therapy

You may not qualify if:

  • diagnosis other than cancer,
  • age younger than 18 years,
  • requesting conventional chemotherapy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Arizona Center for Advanced Medicine

Scottsdale, Arizona, 85258, United States

Location

MeSH Terms

Conditions

Neoplasms

Interventions

Nutrition Therapy

Intervention Hierarchy (Ancestors)

Therapeutics

Study Officials

  • Martha M Grout, MD, MD(H)

    Arizona Center for Advanced Medicine

    PRINCIPAL INVESTIGATOR
0

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 4, 2015

First Posted

November 6, 2015

Study Start

November 1, 2015

Primary Completion

August 1, 2018

Study Completion

August 1, 2018

Last Updated

August 28, 2018

Record last verified: 2018-08

Locations

US(1)